单位(元)汇添富创新医药混合A(006113)资产负债表 |
| 报告期 |
2025/6/30 |
2024/12/31 |
2024/6/30 |
2023/12/31 |
| 资产 |
| 银行存款 |
770,010,713 |
229,759,427 |
724,743,762 |
351,827,619 |
| 结算备付金 |
73,772,500 |
20,209,902 |
8,164,578 |
5,866,122 |
| 存出保证金 |
1,039,060 |
795,859 |
859,915 |
1,163,880 |
| 交易性金融资产 |
8,591,205,315 |
4,179,710,570 |
4,155,385,570 |
6,409,224,579 |
| 其中:股票投资 |
8,589,995,135 |
3,915,643,369 |
3,954,033,767 |
5,874,045,109 |
| 基金投资 |
- |
- |
- |
- |
| 债券投资 |
1,210,179 |
264,067,201 |
201,351,803 |
535,179,470 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
228,195,924 |
- |
- |
| 应收证券清算款 |
- |
26,872,263 |
100,322,180 |
13,667,068 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
2,755,648 |
- |
2,425,912 |
- |
| 应收申购款 |
53,738,381 |
809,190 |
1,320,306 |
2,391,796 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
9,492,521,616 |
4,686,353,135 |
4,993,222,223 |
6,784,141,065 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
197,983,182 |
- |
20,331,431 |
- |
| 应付赎回款 |
3,516,370 |
2,910,894 |
1,975,646 |
3,021,077 |
| 应付管理人报酬 |
8,701,415 |
5,025,552 |
5,115,682 |
6,887,664 |
| 应付托管费 |
1,450,236 |
837,592 |
852,614 |
1,147,944 |
| 应付销售服务费 |
437,020 |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
4,697,942 |
2,228,763 |
3,342,272 |
2,286,802 |
| 负债合计 |
216,786,164 |
11,002,800 |
31,617,643 |
13,343,487 |
| 所有者权益 |
| 实收基金 |
5,589,504,745 |
3,727,146,733 |
4,010,522,075 |
4,250,683,618 |
| 未分配利润 |
3,686,230,707 |
948,203,602 |
951,082,504 |
2,520,113,959 |
| 所有者权益合计 |
9,275,735,452 |
4,675,350,335 |
4,961,604,579 |
6,770,797,577 |
| 负债和所有者权益总计 |
9,492,521,616 |
4,686,353,135 |
4,993,222,223 |
6,784,141,065 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。